Our findings indicated that PKD1 activity, and consequently this neuroprotective pathway, is suppressed by excitotoxicity in both in vitro models and in vivo models of ischemic brain damage, as well as in human ischemic stroke patients [20]. Here, PKD1 is linked to ischemic stroke.